AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

In October 2019, Janet Woodcock, then the director of the US Food and Drug Administration’s Center for Drug Evaluation and ...

Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...

Among publicly insured individuals, those in a historically marginalized group are less likely to initiate biologics prescribed for severe asthma or other indications.

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

Dupixent is the first biologic medicine approved in the U.S. for the common lung condition, though competitors from GSK, AstraZeneca and Roche could follow.

After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with ...

New research shows that infants who were exclusively fed breast milk during their hospitalization right after birth were 22% less likely to develop asthma in early childhood.

The last week of September is known as Asthma Peak Week. During this time of year, asthma worsens and can cause more issues.

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.

The NObreath® measures a person's FeNO level, an important biomarker of lung inflammation, typically associated with asthma.

A massive black market scheme that diverted and resold critical prescription drugs potentially put unsuspecting patients in ...